RAPT Therapeutics (RAPT) Other Working Capital Changes (2020 - 2024)
Historic Other Working Capital Changes for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to -$720000.0.
- Therapeutics' Other Working Capital Changes fell 344.83% to -$720000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.9 million, marking a year-over-year decrease of 546.73%. This contributed to the annual value of -$2.9 million for FY2024, which is 546.73% down from last year.
- Therapeutics' Other Working Capital Changes amounted to -$720000.0 in Q4 2024, which was down 344.83% from -$712000.0 recorded in Q3 2024.
- Over the past 5 years, Therapeutics' Other Working Capital Changes peaked at $5.1 million during Q1 2020, and registered a low of -$1.5 million during Q3 2020.
- For the 5-year period, Therapeutics' Other Working Capital Changes averaged around -$506300.0, with its median value being -$712000.0 (2024).
- Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 9420.89% in 2022, then tumbled by 112857.14% in 2023.
- Over the past 5 years, Therapeutics' Other Working Capital Changes (Quarter) stood at -$1.3 million in 2020, then soared by 41.62% to -$756000.0 in 2021, then skyrocketed by 32.01% to -$514000.0 in 2022, then plummeted by 35.41% to -$696000.0 in 2023, then dropped by 3.45% to -$720000.0 in 2024.
- Its Other Working Capital Changes was -$720000.0 in Q4 2024, compared to -$712000.0 in Q3 2024 and -$712000.0 in Q2 2024.